PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.Shaun G. Goodman, A. Langer, Lyall Higginson et al.|PubMed|1996Cited by 3
Impact of medical interventions on quality of life in cardiovascular disease: a consensus viewpoint.Jennifer M. Arnold, W. Warnica, Zion Sasson et al.|PubMed|1997Cited by 1